◷
New version applies from 07/07/2018.
1 provision changes.
Later versions: 13/01/2021, 03/10/2022, 20/02/2023, 03/06/2024, 14/08/2025, 18/09/2026.
Regulation (EC) No 273/2004
30/12/2013 → 21/09/2016: 0 inserted · 0 removed · 26 amended · 0 moved · 0 renamed · 18 unchanged
Position-only shifts inside the same heading are not changes. Amended = the printed text changed.
Preamble
- amended Preamble
Recitals
- amended Recital 1
- amended Recital 2
- amended Recital 3
- amended Recital 4
- amended Recital 5
- amended Recital 6
- amended Recital 7
- amended Recital 8
- amended Recital 9
- amended Recital 10
- amended Recital 11
- amended Recital 12
- amended Recital 13
- amended Recital 14
- amended Recital 15
- amended Recital 16
- amended Recital 17
- amended Recital 18
Outside any heading
- amended Article 2 - Definitions
- amended Article 3 - Requirements for the placing on the market of scheduled substances
- amended Article 11 - Cooperation between the Member States and the Commission
- amended Article 13a - European database on drug precursors
- amended Article 14a - Committee procedure
Outside any heading · 17 unchanged
Article 1 · Article 4 · Article 5 · Article 6 · Article 7 · Article 8 · Article 9 · Article 10 · Article 12 · Article 13 · Article 13b · Article 14 · Article 15 · Article 15a · Article 16 · Article 17 · Article 18
Annexes
- amended Annex I - List of scheduled substances
- amended Annex III - 1.Model declaration relating to individual transactions (category 1 or 2)